Navigation Links
Ranbaxy Launches Asthma Inhalation Capsule in India

Pharma major Ranbaxy Laboratories Ltd Tuesday launched its branded inhalation capsules in India for the treatment of asthma//.

A unique combination of long acting Beta2-agonist Formoterol and the most potent inhaled corticosteroid Fluticasone, the inhalation capsule Avessa is available as Rheocaps Avessa 100 mcg, Avessa 250 mcg, Avessa 500 mcg, depending on the severity of Asthma.

The product is to be used only with the Rheohaler - the world's first capsule-based multi-dose dry powder inhaler, Ranbaxy stated Tuesday.

"We are delighted to launch the world's first unique combination product Avessa in India, which reinforces our strong commitment to develop and introduce convenient solutions for asthmatic patients," said Sanjeev I. Dani, regional director of Ranbaxy for India and the Middle East.

Earlier this year, Ranbaxy had launched Osonide (Ciclesonide) Inhaler, a novel once-a-day product for asthma patients.

In May Ranbaxy entered into an in-licensing agreement for the Indian market with the Netherlands-based pharma company, Eurodrug Laboratories, for the asthma product Doxophylline - a novel Xanthine bronchodilator, sold under the brand name 'Synasma'.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/11/2016)... ... December 11, 2016 , ... Traditional cell phone chargers serve a very ... case for chargers used for tablets, portable laptops, and other mobile devices with rechargeable ... charges its respective device. An inventor from Floral Park, N.Y., has developed the patent-pending ...
(Date:12/11/2016)... ... , ... It’s hard for an inventor from Hanover, Pa., to spend time ... eyes and general discomfort associated with allergic reactions, he decided to develop an easy ... the patent-pending CLEAN AIR NOSE FILTER, an accessory that provides relief of allergic reactions ...
(Date:12/11/2016)... FL (PRWEB) , ... December 11, 2016 , ... ... to the online market. Skinerals Organic Skin Science has introduced 16 new products ... explains Michael Schindele, creator of Skinerals, "And we wanted to supply more products ...
(Date:12/11/2016)... , ... December 11, 2016 , ... ... has announced its 2017 program schedule, now available online. This year’s conference event ... research concerning eating disorders. The dynamic Symposium will take place March 22 - ...
(Date:12/10/2016)... ... December 09, 2016 , ... ... survival rates have increased greatly in recent years. This can be attributed to ... that progress hasn’t been equally distributed. In response, Mediaplanet’s latest, cross-platform edition of ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)...  Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... filed a lawsuit for patent infringement.  The lawsuit, filed ... of Delaware , alleges that Nevro ... stimulation leads, batteries, and telemetry units. ...
(Date:12/9/2016)... 2016 MSD, a nationally recognized supplier of ... alternate site health care facilities, announced today that it ... ("First Choice"), a privately held national distributor of medical ... home health segments. We would like to welcome First ... compelling transaction will deliver significant and immediate value to ...
(Date:12/9/2016)... , December 9, 2016 ... Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization ... Defibrillators, Wearable Cardioverter Defibrillators The ... at a CAGR of 5.3% from 2016-2020 and ... expected to grow at a CAGR of 5.2% ...
Breaking Medicine Technology: